Tamyra Trice
Physician Assistant · Milwaukee, WINPI 1740291483
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Gilead at 39.8% of the total. Reporting peaked in 2022 at $6,350 and has fallen 80.8% since, to $1,221 in 2025. Among physician assistant clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $38.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- AstraZeneca$3K
- AbbVie$1K
- Lilly USA, LLC$378
- Pfizer$357
- Novo Nordisk$215
- plus $2K from 24 others
What the payments were for
- Consulting fees$3,78037%
- Travel & lodging$1,30713%
- Food & beverage$5,24751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 42 | $4,115 |
| AstraZeneca | 40 | $2,747 |
| AbbVie | 60 | $1,006 |
| Lilly USA, LLC | 23 | $378 |
| Pfizer | 15 | $357 |
| Novo Nordisk | 12 | $215 |
| Bayer | 9 | $153 |
| ANI Pharmaceuticals, Inc. | 1 | $119 |
| Aimmune Therapeutics, Inc. | 5 | $102 |
| Alnylam Pharmaceuticals Inc. | 4 | $99 |
| GSK | 6 | $95 |
| Novartis | 5 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $93 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $92 |
| Johnson & Johnson | 4 | $82 |
| Merck | 5 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Exact Sciences | 3 | $64 |
| Boehringer Ingelheim | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Nestle Healthcare Nutrition Inc. | 2 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
| Sanofi Pasteur Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Abbott | 1 | $17 |
| Viiv Healthcare Company | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$3,359
- FARXIGA$1,740
- LOKELMA$298
- PURIFIED CORTROPHIN GEL$119
How this compares
$10,335 in reported general payments places this provider in the 95th percentile of 2,804 physician assistant providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 114 | $83,563 |
| LinzessLinaclotide | 76 | $65,806 |
| FarxigaDapagliflozin Propanediol | 72 | $64,484 |
| OzempicSemaglutide | 64 | $63,258 |
| TrulicityDulaglutide | 34 | $45,206 |
| MyrbetriqMirabegron | 51 | $33,784 |
| JardianceEmpagliflozin | 32 | $31,561 |
| ZenpepLipase/Protease/Amylase | 19 | $25,711 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 47 | $23,492 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $21,473 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $18,317 |
| XareltoRivaroxaban | 23 | $16,979 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $14,967 |
| Xigduo XrDapaglifloz Propaned/Metformin | 16 | $13,899 |
| BelsomraSuvorexant | 29 | $12,802 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $95 | $124,847203 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $2,747 | $86,591114 claims |
| Novo NordiskOzempic, Rybelsus | $215 | $74,04475 claims |
| AbbVieLinzess | $1,006 | $65,80676 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $64 | $52,46471 claims |
| Lilly USA, LLCTrulicity | $378 | $45,20634 claims |
| Astellas Pharma US IncMyrbetriq, Veozah | $42 | $41,08964 claims |
| Aimmune Therapeutics, Inc.Zenpep | $102 | $25,71119 claims |
| Johnson & JohnsonXarelto | $82 | $16,97923 claims |
| MerckBelsomra | $82 | $12,80229 claims |
| PfizerEliquis | $357 | $9,41516 claims |
| BayerKerendia | $153 | $7,13311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,804 physician assistant providers in Wisconsin.
Other physician assistant in Milwaukee
- Lisa SershonMilwaukee$182K
- Charnai SherryMilwaukee$45K
- Joseph FraneckiMilwaukee$27K
- Caroline JosephMilwaukee$17K
- Kimberly Roller-VoigtMilwaukee$15K
- Dylan MenefeeMilwaukee$14K
- Amanda MuellerMilwaukee$13K
- Dalton MenkeMilwaukee$11K
- Jacqueline HaleMilwaukee$8K
- Alecia BoederMilwaukee$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.